Isoquinoline

Isoquinoline

SCHEMBL1743732

c1ccc2cnccc2c1.c1cscn1

nearest known ligand 0.37

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TNF P01375 1/20 0.37
KDM4E B2RXH2 4/20 0.36
CYP3A4 P08684 3/20 0.36
CYP2C9 P11712 2/20 0.36
CYP2C19 P33261 2/20 0.36
LMNA P02545 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2D6 P10635 1/20 0.36
MAPKAPK2 P49137 1/20 0.36
EGFR P00533 1/20 0.35
MAPT P10636 1/20 0.35
CYP17A1 P05093 1/20 0.34
CYP19A1 P11511 1/20 0.34
CYP11B1 P15538 1/20 0.34
CYP11B2 P19099 1/20 0.34
IMPDH2 P12268 1/20 0.34
HTT P42858 4/20 0.33
PRKCZ Q05513 1/20 0.33
POLB P06746 1/20 0.33
RAD52 P43351 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Isoquinoline SCHEMBL29501078 1.00 TNF (0.37) TNFKDM4ECYP3A4CYP2C9CYP2C19
Naphthalene SCHEMBL303703 0.88 CYP2A6 (0.40) EGFRCYP17A1CYP19A1CYP11B1CYP11B2
Isoquinoline SCHEMBL27756923 0.87 ALDH1A1 (0.50) KDM4ECYP3A4CYP2C19CYP1A2EGFR
Isoquinoline SCHEMBL28313825 0.82 TNF (0.40) TNFKDM4ECYP3A4CYP2C9CYP2C19
Isoquinoline SCHEMBL30286035 0.81 TNF (0.48) TNFKDM4ECYP3A4CYP2C9CYP2C19
Isoquinoline SCHEMBL29355164 0.81 TNF (0.48) TNFKDM4ECYP3A4CYP2C9CYP2C19
Isoquinoline SCHEMBL31588723 0.81 TNF (0.48) TNFKDM4ECYP3A4CYP2C9CYP2C19
Naphthalene SCHEMBL7327012 0.81 TNF (0.48) TNFKDM4ECYP3A4CYP2C9CYP2C19
Isoquinoline SCHEMBL9654 0.81 TNF (0.48) TNFKDM4ECYP3A4CYP2C9CYP2C19
Isoquinoline SCHEMBL1536317 0.81 TNF (0.48) TNFKDM4ECYP3A4CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114380848-B Preparation and application of isoquinoline thiazole salt and derivatives thereof 华南农业大学 2023-03-14 CN claimed
CN-114380848-A Preparation and application of isoquinoline thiazole salt and derivatives thereof 华南农业大学 2022-04-22 CN claimed
CN-114409602-B Method for synthesizing alpha-keto acid by using oxalyl chloride and Grignard reagent as raw materials 武汉大学 2024-01-30 CN disclosed
CN-114380848-B Preparation and application of isoquinoline thiazole salt and derivatives thereof 华南农业大学 2023-03-14 CN disclosed
CN-114380848-B Preparation and application of isoquinoline thiazole salt and derivatives thereof 华南农业大学 2023-03-14 CN disclosed
CN-114380848-B Preparation and application of isoquinoline thiazole salt and derivatives thereof 华南农业大学 2023-03-14 CN disclosed
CN-114409602-A Method for synthesizing alpha-keto acid by using oxalyl chloride and Grignard reagent as raw materials 武汉大学 2022-04-29 CN disclosed
CN-114380848-A Preparation and application of isoquinoline thiazole salt and derivatives thereof 华南农业大学 2022-04-22 CN disclosed
CN-114380848-A Preparation and application of isoquinoline thiazole salt and derivatives thereof 华南农业大学 2022-04-22 CN disclosed
CN-114380848-A Preparation and application of isoquinoline thiazole salt and derivatives thereof 华南农业大学 2022-04-22 CN disclosed
EP-2387570-A1 FLUOROISOQUINOLINE SUBSTITUTED THIAZOLE COMPOUNDS AND METHODS OF USE Amgen, Inc (US) 2011-11-23 EP disclosed
US-20110263647-A1 FLUOROISOQUINOLINE SUBSTITUTED THIAZOLE COMPOUNDS AND METHODS OF USE AMGEN INC. (US) 2011-10-27 US disclosed
CN-101657583-B Fractionation of a lignocellulosic material UNIV QUEENSLAND 2011-09-28 CN disclosed
WO-2010083246-A1 FLUOROISOQUINOLINE SUBSTITUTED THIAZOLE COMPOUNDS AND METHODS OF USE AMGEN INC. (US) 2010-07-22 WO disclosed
CN-101657583-A Fractionation of a lignocellulosic material UNIV QUEENSLAND AU 2010-02-24 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110263647-A1 FLUOROISOQUINOLINE SUBSTITUTED THIAZOLE COMPOUNDS AND METHODS OF USE TFEB, PCK2, JAK2 TNF 786/4885KDM4E 3719/4885CYP3A4 2741/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.